Because haematological cells, both cancer and primary cells, have clear responses to treatment with APIM-peptides [3, 10], F in KFAGR in ENO1 was mutated in the haploid chronic myeloid leukaemia cell line HAP1. Here, ENO1 is linked to cancer.